Kristopher M. Kirmess

MedicineChemistryBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease”.

Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease

Alzheimer s & Dementia(2023)10.1002/alz.13542

N/A

3.4DataRank · unranked

149 citations

Oliver Langford, Rema Raman, Michael Donohue, Sara Abdel‐Latif, Matthew R. Meyer +16 more

A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis

Molecular Neurodegeneration(2021)10.1186/s13024-021-00451-6

N/A

0DataRank · unranked

233 citations

Kristopher M. Kirmess, Matthew R. Meyer, Mary S. Holubasch, S Knapik, Yan Hu +10 more

The PrecivityAD™ test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis

Clinica Chimica Acta(2021)10.1016/j.cca.2021.05.011

N/A

0DataRank · unranked

134 citations

Matthew R. Meyer, Mary S. Holubasch, S Knapik, Yan Hu, Erin N. Jackson +8 more

Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light

Neurology(2022)10.1212/wnl.0000000000200358

N/A

0DataRank · unranked

148 citations

Thomas K. Karikari, Nicholas J. Ashton, Rachel L. Henson, Kevin E. Yarasheski, Tim West +16 more

Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40

Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring(2023)10.1002/dad2.12405

N/A

0DataRank · unranked

30 citations

Brian A. Gordon, Anna H. Boerwinkle, Patrick H. Luckett, James G. Bollinger, Vitaliy Ovod +12 more

Plasma Aβ42/40 and cognitive variability are associated with cognitive function in Black Americans: Findings from the AA‐FAIM cohort

Alzheimer s & Dementia Translational Research & Clinical Interventions(2023)10.1002/trc2.12414

N/A

0DataRank · unranked

3 citations

Carol A. Van Hulle, Rebecca Langhough, Derek Norton, Megan Zuelsdorff, Diane C. Gooding +19 more

Clinical validation of the PrecivityAD2 blood test: A mass spectrometry‐based test with algorithm combining %p‐tau217 and Aβ42/40 ratio to identify presence of brain amyloid

Alzheimer s & Dementia(2024)10.1002/alz.13764

N/A

0DataRank · unranked

112 citations

Kristopher M. Kirmess, Stephanie Eastwood, Traci L. Wente‐Roth, Faith Irvin, Mary S. Holubasch +20 more

Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset

Annals of Neurology(2024)10.1002/ana.26891

N/A

0DataRank · unranked

88 citations

Daniel Yen, Rachel Hendrix, Brian A. Gordon, Sibonginkhosi L. Dlamini, Nicolas R. Barthélemy +17 more

PrecivityAD2™ Blood Test: Analytical Validation of an LC-MS/MS Assay for Quantifying Plasma Phospho-tau217 and Non-Phospho-tau217 Peptide Concentrations That Are Used with Plasma Amyloid-β42/40 in a Multianalyte Assay with Algorithmic Analysis for Detecting Brain Amyloid Pathology

Diagnostics(2024)10.3390/diagnostics14161739

N/A

0DataRank · unranked

14 citations

Matthew R. Meyer, Kristopher M. Kirmess, Traci L. Wente‐Roth, Faith Irvin, Mary S. Holubasch +6 more

Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients

Annals of Neurology(2024)10.1002/ana.27027

N/A

0DataRank · unranked

7 citations

Suzanne E. Schindler, Amber Salter, Dana C. Perantie, Nicole Shelley, Bradley Judge +14 more

Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group

Alzheimer s & Dementia(2021)10.1002/alz.12510

N/A

0DataRank · unranked

247 citations

Els O. Misdorp, Jannet Koelewijn, Andrew J. Ball, Kaj Blennow, Jeffrey L. Dage +17 more

Prolonged fasting promotes systemic inflammation and platelet activation in humans: A medically supervised, water-only fasting and refeeding study

Molecular Metabolism(2025)10.1016/j.molmet.2025.102152

N/A

0DataRank · unranked

12 citations

María Lastra Cagigas, Andrius Masedunskas, Giovanna Petrucci, Valeria Tosti, Isabella De Ciutiis +10 more